Literature DB >> 28673692

Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma.

Wim van Boxtel1, Eline Boon2, Willem L J Weijs3, Frank J A van den Hoogen4, Uta E Flucke5, Carla M L van Herpen6.   

Abstract

Entities:  

Keywords:  Ado-trastuzumab emtansine; Docetaxel; Head and Neck Neoplasms; Neoplasm metastasis; Pertuzumab; Receptor, ErbB-2; Salivary duct carcinoma; Salivary gland neoplasms; Trastuzumab

Mesh：

Substances：

Year:  2017        PMID： 28673692     DOI： 10.1016/j.oraloncology.2017.06.023

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  9 in total

1.  Molecular patterns in salivary duct carcinoma identify prognostic subgroups.

Authors:  Ruta Gupta; Mark J Cowley; Simon A Mueller; Marie-Emilie A Gauthier; James Blackburn; John P Grady; Spiridoula Kraitsek; Elektra Hajdu; Matthias S Dettmer; Jane E Dahlstrom; C Soon Lee; Peter P Luk; Bing Yu; Roland Giger; Sarah Kummerfeld; Jonathan R Clark
Journal:  Mod Pathol       Date:  2020-05-26       Impact factor: 7.842

2.  First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition.

Authors:  Victor T G Lin; Lisle M Nabell; Sharon A Spencer; William R Carroll; Shuko Harada; Eddy S Yang
Journal:  J Natl Compr Canc Netw       Date:  2018-10       Impact factor: 11.908

3.  Educational Case: Diagnostic Approach to Salivary Gland Neoplasms.

Authors:  Preeti Malik; Saeed Asiry; D Yitzchak Goldstein; Samer N Khader
Journal:  Acad Pathol       Date:  2021-05-25

4.  Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.

Authors:  Eline Boon; Wim van Boxtel; Jan Buter; Robert J Baatenburg de Jong; Robert J J van Es; Miranda Bel; Edward Fiets; Sjoukje F Oosting; Marije Slingerland; Ann Hoeben; Margot E T Tesselaar; Marianne A Jonker; Uta E Flucke; Winette T A van der Graaf; Carla M L van Herpen
Journal:  Head Neck       Date:  2017-12-22       Impact factor: 3.147

5.  Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.

Authors:  Stacey M Gargano; Wijendra Senarathne; Rebecca Feldman; Elena Florento; Phillip Stafford; Jeffrey Swensen; Semir Vranic; Zoran Gatalica
Journal:  Cancer Med       Date:  2019-10-14       Impact factor: 4.452

6.  Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.

Authors:  Wim van Boxtel; Gerald W Verhaegh; Ilse A van Engen-van Grunsven; Dianne van Strijp; Leonie I Kroeze; Marjolein J Ligtenberg; Hans B van Zon; Yara Hendriksen; Diederick Keizer; Anja van de Stolpe; Jack A Schalken; Carla M van Herpen
Journal:  Int J Cancer       Date:  2019-12-12       Impact factor: 7.396

7.  The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy.

Authors:  Natsuki Saigusa; Hideaki Hirai; Yuichiro Tada; Daisuke Kawakita; Masato Nakaguro; Kiyoaki Tsukahara; Satoshi Kano; Hiroyuki Ozawa; Takahito Kondo; Kenji Okami; Takafumi Togashi; Yukiko Sato; Makoto Urano; Manami Kajiwara; Tomotaka Shimura; Chihiro Fushimi; Akira Shimizu; Isaku Okamoto; Takuro Okada; Takayoshi Suzuki; Yorihisa Imanishi; Yoshihiro Watanabe; Akihiro Sakai; Koji Ebisumoto; Yuichiro Sato; Yoshitaka Honma; Keisuke Yamazaki; Yushi Ueki; Toyoyuki Hanazawa; Yuki Saito; Hideaki Takahashi; Mizuo Ando; Shinji Kohsaka; Takashi Matsuki; Toshitaka Nagao
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

8.  Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.

Authors:  Daisuke Kawakita; Toshitaka Nagao; Hideaki Takahashi; Satoshi Kano; Yoshitaka Honma; Hideaki Hirai; Natsuki Saigusa; Kohei Akazawa; Kaori Tani; Hiroya Ojiri; Kiyoaki Tsukahara; Hiroyuki Ozawa; Kenji Okami; Takahito Kondo; Takafumi Togashi; Chihiro Fushimi; Tomotaka Shimura; Akira Shimizu; Isaku Okamoto; Takuro Okada; Yorihisa Imanishi; Yoshihiro Watanabe; Kuninori Otsuka; Akihiro Sakai; Koji Ebisumoto; Yuichiro Sato; Keisuke Yamazaki; Yushi Ueki; Toyoyuki Hanazawa; Yuki Saito; Mizuo Ando; Takashi Matsuki; Masato Nakaguro; Yukiko Sato; Makoto Urano; Yoshitaka Utsumi; Shinji Kohsaka; Takashi Saotome; Yuichiro Tada
Journal:  Ther Adv Med Oncol       Date:  2022-09-06       Impact factor: 5.485

9.  68Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study.

Authors:  Wim van Boxtel; Susanne Lütje; Ilse C H van Engen-van Grunsven; Gerald W Verhaegh; Jack A Schalken; Marianne A Jonker; James Nagarajah; Martin Gotthardt; Carla M L van Herpen
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.